Search

Search Constraints

You searched for: Author/Creator Singhal, N.

Search Results

1. 126P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) in patients (pts) with checkpoint inhibitor (CPI)-experienced advanced non-small cell lung cancer (NSCLC). (December 2022)

2. 148P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC). (December 2022)

3. 2241 Outcome of peptide receptor radionuclide therapy with 177Luoctreotate in advanced neuroendocrine tumours (NET): South Australian sub study of the SIGNETURe Registry. (September 2015)

6. Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly. (3rd June 2016)